Principles of modular tumor therapy
- PMID: 19593676
- PMCID: PMC2756340
- DOI: 10.1007/s12307-009-0023-x
Principles of modular tumor therapy
Abstract
Nature is interwoven with communication and is represented and reproduced through communication acts. The central question is how may multimodal modularly acting and less toxic therapy approaches, defined as modular therapies, induce an objective response or even a continuous complete remission, although single stimulatory or inhibitingly acting drugs neither exert mono-activity in the respective metastatic tumor type nor are they directed to potentially 'tumor-specific' targets. Modularity in the present context is a formal pragmatic communicative systems concept, describing the degree to which systems objects (cells, pathways etc.) may be communicatively separated in a virtual continuum, and recombined and rededicated to alter validity and denotation of communication processes in the tumor. Intentional knowledge, discharging in reductionist therapies, disregards the risk-absorbing background knowledge of the tumor's living world including the holistic communication processes, which we rely on in every therapy. At first, this knowledge constitutes the validity of informative intercellular processes, which is the prerequisite for therapeutic success. All communication-relevant steps, such as intentions, understandings, and the appreciation of messages, may be modulated simultaneously, even with a high grade of specificity. Thus, modular therapy approaches including risk-absorbing and validity-modifying background knowledge may overcome reductionist idealizations. Modular therapies show modular events assembled by the tumor's living world as an additional evolution-constituting dimension. This way, modular knowledge may be acquired from the environment, either incidentally or constitutionally. The new communicatively defined modular coherency of environment, i.e. the tumor-associated microenvironment, and tumor cells open novel ways for the scientific community in 'translational medicine'.
Figures
Similar articles
-
Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia.Cancer Microenviron. 2015 Aug;8(2):75-92. doi: 10.1007/s12307-015-0170-1. Epub 2015 Aug 11. Cancer Microenviron. 2015. PMID: 26259724 Free PMC article.
-
Rules to be adopted for publishing a scientific paper.Ann Ital Chir. 2016;87:1-3. Ann Ital Chir. 2016. PMID: 28474609
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Risk management frameworks for human health and environmental risks.J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608. J Toxicol Environ Health B Crit Rev. 2003. PMID: 14698953 Review.
-
Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis.Front Pharmacol. 2018 Nov 28;9:1357. doi: 10.3389/fphar.2018.01357. eCollection 2018. Front Pharmacol. 2018. PMID: 30546308 Free PMC article. Review.
Cited by
-
Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue-Going Beyond Apoptosis Induction.Front Oncol. 2019 Dec 20;9:1408. doi: 10.3389/fonc.2019.01408. eCollection 2019. Front Oncol. 2019. PMID: 31921665 Free PMC article. Review.
-
Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia.Cancer Microenviron. 2015 Aug;8(2):75-92. doi: 10.1007/s12307-015-0170-1. Epub 2015 Aug 11. Cancer Microenviron. 2015. PMID: 26259724 Free PMC article.
-
Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue.Int J Mol Sci. 2018 Nov 9;19(11):3540. doi: 10.3390/ijms19113540. Int J Mol Sci. 2018. PMID: 30424016 Free PMC article. Review.
-
Modular therapy approach in metastatic castration-refractory prostate cancer.World J Urol. 2010 Dec;28(6):745-50. doi: 10.1007/s00345-010-0567-x. Epub 2010 May 19. World J Urol. 2010. PMID: 20490506 Clinical Trial.
-
Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance.Cancers (Basel). 2023 Dec 29;16(1):180. doi: 10.3390/cancers16010180. Cancers (Basel). 2023. PMID: 38201607 Free PMC article. Review.
References
-
- Hochhaus A. First-Line management of CML: a state of the art review. J Natl Compr Canc Netw. 2008;6(Suppl 2):S1–S10. - PubMed
-
- Trosko JE. Gap junctional intercellular communication as a biological “Rosetta stone” in understanding, in a systems biological manner, stem cell behavior, mechanisms of epigenetic toxicology, chemoprevention and chemotherapy. J Membr Biol. 2007;218:93–100. doi: 10.1007/s00232-007-9072-6. - DOI - PubMed
-
- Aebersold R, Auffray C, Baney E, Barillot E, Brazma A, Brett C, Brunak S, Butte A, Califano A, Celis J, Cufer T, Ferrell J, Galas D, Gallahan D, Gatenby R, Goldbeter A, Hace N, Henney A, Hood L, Iyengar R, Jackson V, Kallioniemi O, Klingmuller U, Kolar P, Kolch W, Kyriakopoulou C, Laplace F, Lehrach H, Marcus F, Matrisian L, Nolan G, Pelkmans L, Potti A, Sander C, Seljak M, Singer D, Sorger P, Stunnenberg H, Superti-Furga G, Uhlen M, Vidal M, Weinstein J, Wigle D, Williams M, Wolkenhauer O, Zhivotovsky B, Zinovyev A, Zupan B. Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008) Mol Oncol. 2009;3:9–17. doi: 10.1016/j.molonc.2008.11.003. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources